|
1
|
Retracted
Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
|
Anesth Analg
|
2009
|
2.58
|
|
2
|
Retracted
Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin.
|
Crit Care Med
|
2007
|
1.51
|
|
3
|
Retracted
The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients.
|
Intensive Care Med
|
2008
|
0.93
|
|
4
|
Retracted
The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients.
|
Anesth Analg
|
2004
|
0.81
|
|
5
|
Retracted
Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
|
J Cardiothorac Vasc Anesth
|
2010
|
0.79
|
|
6
|
Retracted
Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation, and markers of organ function.
|
Intensive Care Med
|
2002
|
0.79
|
|
7
|
Does coagulation differ between elderly and younger patients undergoing cardiac surgery?
|
Intensive Care Med
|
2002
|
0.78
|